Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of CAD 165.05 billion. The enterprise value is 187.45 billion.
| Market Cap | 165.05B |
| Enterprise Value | 187.45B |
Important Dates
The last earnings date was Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | May 6, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.18% |
| Shares Change (QoQ) | +0.28% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 42.92% |
| Float | 1.08B |
Valuation Ratios
The trailing PE ratio is 25.34 and the forward PE ratio is 9.38.
| PE Ratio | 25.34 |
| Forward PE | 9.38 |
| PS Ratio | 2.01 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 19.49 |
| P/FCF Ratio | 10.27 |
| P/OCF Ratio | 8.56 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.04, with an EV/FCF ratio of 11.66.
| EV / Earnings | 27.83 |
| EV / Sales | 2.34 |
| EV / EBITDA | 8.04 |
| EV / EBIT | 10.70 |
| EV / FCF | 11.66 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.12 |
| Quick Ratio | 0.21 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.32 |
| Debt / FCF | 1.99 |
| Interest Coverage | 18.00 |
Financial Efficiency
Return on equity (ROE) is 5.71% and return on invested capital (ROIC) is 9.27%.
| Return on Equity (ROE) | 5.71% |
| Return on Assets (ROA) | 5.46% |
| Return on Invested Capital (ROIC) | 9.27% |
| Return on Capital Employed (ROCE) | 11.30% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.10M |
| Profits Per Employee | 89,992 |
| Employee Count | 74,846 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 0.53 |
Taxes
In the past 12 months, Sanofi has paid 2.77 billion in taxes.
| Income Tax | 2.77B |
| Effective Tax Rate | 29.05% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 19.69 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 79.17 |
| Average Volume (20 Days) | 2,292 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of CAD 82.19 billion and earned 6.74 billion in profits. Earnings per share was 0.88.
| Revenue | 82.19B |
| Gross Profit | 61.05B |
| Operating Income | 18.31B |
| Pretax Income | 9.53B |
| Net Income | 6.74B |
| EBITDA | 23.82B |
| EBIT | 18.31B |
| Earnings Per Share (EPS) | 0.88 |
Balance Sheet
The company has 9.62 billion in cash and 31.99 billion in debt, with a net cash position of -22.37 billion.
| Cash & Cash Equivalents | 9.62B |
| Total Debt | 31.99B |
| Net Cash | -22.37B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 118.07B |
| Book Value Per Share | 15.88 |
| Working Capital | 5.55B |
Cash Flow
In the last 12 months, operating cash flow was 19.28 billion and capital expenditures -3.20 billion, giving a free cash flow of 16.08 billion.
| Operating Cash Flow | 19.28B |
| Capital Expenditures | -3.20B |
| Depreciation & Amortization | 5.37B |
| Net Borrowing | 2.37B |
| Free Cash Flow | 16.08B |
| FCF Per Share | n/a |
Margins
Gross margin is 74.29%, with operating and profit margins of 22.28% and 8.20%.
| Gross Margin | 74.29% |
| Operating Margin | 22.28% |
| Pretax Margin | 11.59% |
| Profit Margin | 8.20% |
| EBITDA Margin | 28.98% |
| EBIT Margin | 22.28% |
| FCF Margin | 20.04% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 3.59%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 3.59% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 232.05% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.18% |
| Shareholder Yield | 5.77% |
| Earnings Yield | 3.95% |
| FCF Yield | 9.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |